Industry

TEL AVIV, Israel–(BUSINESS WIRE)–#aipowered–Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, today announced the appointment of Kenneth J. Bloom, MD, FCAP as the company’s new head of pathology. Dr. Bloom brings more than 35 years of clinical experience in pathology, oncology, telemedicine and bioinformatics to this … [Read more…]

TORONTO–(BUSINESS WIRE)–Messagepoint announced today it has been named a Leader in the 2022 Aspire Leaderboard™ for customer communications management (CCM) and customer experience management (CXM) for the fifth consecutive year. Specifically, Messagepoint has been recognized as a leading provider in both the Vendor Hosted SaaS CCM grid, as well as the AnyPrem CCM Software grid … [Read more…]

NEW YORK–(BUSINESS WIRE)–Audax Private Debt (“Audax”), as Administrative Agent and Joint Lead Arranger, and Adams Street Partners, as Joint Lead Arranger, provided a senior secured credit facility to support US Med-Equip’s (“USME” or the “Company”) acquisition of Freedom Medical, a leading provider of rental medical equipment and related outsourced support services to hospitals and long-term … [Read more…]

MONTREAL–(BUSINESS WIRE)–#AIDS2022–As the world’s largest HIV/AIDS conference, AIDS 2022, is set to conclude today – amid a visa scandal that barred many advocates from the most HIV-affected countries in the Global South – AHF calls for UNAIDS and WHO to place a renewed and urgent focus on HIV testing and treatment initiation and retention. Those … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Female Sterilization Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. Female Sterilization Devices Market report is built to visualize quantitative market trends within Reproductive Health Devices therapeutic area. The model discusses in detail … [Read more…]

Published studies show improved immunogenicity of PharmaJet System for DNA vaccines GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a biotech company that, with their innovative needle-free technology, has developed a more effective way of administering drugs and biologics to accelerate research, commercialization and public health outcomes, announced that its partner, Scancell, will include needle-free delivery of their Phase 2 … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–Element Science, an innovative health technology company pioneering a next-generation digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, today announced the first patient save from a successful defibrillation early in the enrollment of the Investigational Device Exception (IDE) Study of its Jewel Patch Wearable Cardioverter Defibrillator (P-WCD). The Jewel … [Read more…]

Appointments support accelerated growth of proprietary mesh technology ST. PAUL, Minn.–(BUSINESS WIRE)–Spineology Inc., the longtime leader in ultra-minimally invasive spine surgery, announces the promotion of Matt Cronin to Chief Commercial Officer. Cronin will lead Spineology’s commercial team of sales, marketing and medical education, driving the company’s commercial strategy. “Having worked with Matt the last year … [Read more…]

JACKSONVILLE, Ill.–(BUSINESS WIRE)–Turner Scientific, a world leader in laboratory monitoring and nonclinical hearing research, is pleased to announce that Cindy Buckmaster, Ph.D., has joined its laboratory monitoring team as Chief Operating Officer of Facility Monitoring Services. Dr. Buckmaster was previously the Director of the Center for Comparative Medicine at Baylor College of Medicine and is … [Read more…]

Researchers to highlight positive results from a phase 3 clinical study for treatment of agitation in patients with Alzheimer’s dementia PRINCETON, N.J. & DEERFIELD, Ill.–(BUSINESS WIRE)–Otsuka Pharmaceutical Development & Commercialization, Inc., and H. Lundbeck A/S (Lundbeck) today announce that new Phase 3 data for brexpiprazole will be presented at the 2022 Alzheimer’s Association International Conference … [Read more…]